ARCHIVES

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI To Supply Maytansine For Several Phase I Studies; Holleb Urges Referrals To “Experts”

March 26, 1976

DCPC Board Will Consider Revised Concepts For CPRUs

September 18, 1987

Rall Supports Animal Tests; Carcinogenesis Reports Summarized

May 13, 1977

FDA Adopts Final Diagnostics X-Ray Rule Amendment

September 9, 1977

Panel Calls For New Office, Advisory Groups To Oversee NCI’s Translational Research.

June 22, 2007

Study Needs 23,000 Women Whose Sisters Have Cancer

September 29, 2006